nodes	percent_of_prediction	percent_of_DWPC	metapath
Pamidronate—Histamine Phosphate—CYP2C9—brain cancer	0.00923	1	CrCbGaD
Pamidronate—FDPS—telencephalon—brain cancer	0.00328	0.13	CbGeAlD
Pamidronate—FDPS—gonad—brain cancer	0.00274	0.109	CbGeAlD
Pamidronate—FDPS—pituitary gland—brain cancer	0.00267	0.106	CbGeAlD
Pamidronate—Cardiac failure—Etoposide—brain cancer	0.00263	0.00273	CcSEcCtD
Pamidronate—Confusional state—Procarbazine—brain cancer	0.00263	0.00272	CcSEcCtD
Pamidronate—Vomiting—Lomustine—brain cancer	0.00261	0.00271	CcSEcCtD
Pamidronate—Oedema—Procarbazine—brain cancer	0.00261	0.0027	CcSEcCtD
Pamidronate—Neutropenia—Temozolomide—brain cancer	0.00259	0.00269	CcSEcCtD
Pamidronate—Infection—Procarbazine—brain cancer	0.00259	0.00268	CcSEcCtD
Pamidronate—Angiopathy—Hydroxyurea—brain cancer	0.00258	0.00267	CcSEcCtD
Pamidronate—Upper respiratory tract infection—Temozolomide—brain cancer	0.00258	0.00267	CcSEcCtD
Pamidronate—FDPS—medulla oblongata—brain cancer	0.00258	0.102	CbGeAlD
Pamidronate—Pneumonia—Carmustine—brain cancer	0.00257	0.00267	CcSEcCtD
Pamidronate—Shock—Procarbazine—brain cancer	0.00257	0.00266	CcSEcCtD
Pamidronate—Thrombocytopenia—Procarbazine—brain cancer	0.00255	0.00265	CcSEcCtD
Pamidronate—Chills—Hydroxyurea—brain cancer	0.00255	0.00264	CcSEcCtD
Pamidronate—Tachycardia—Procarbazine—brain cancer	0.00255	0.00264	CcSEcCtD
Pamidronate—Hyperhidrosis—Procarbazine—brain cancer	0.00252	0.00261	CcSEcCtD
Pamidronate—Renal failure—Carmustine—brain cancer	0.00252	0.00261	CcSEcCtD
Pamidronate—Alopecia—Hydroxyurea—brain cancer	0.00251	0.0026	CcSEcCtD
Pamidronate—Stomatitis—Carmustine—brain cancer	0.0025	0.00258	CcSEcCtD
Pamidronate—Urinary tract infection—Carmustine—brain cancer	0.00249	0.00258	CcSEcCtD
Pamidronate—Pneumonia—Temozolomide—brain cancer	0.00249	0.00258	CcSEcCtD
Pamidronate—Anorexia—Procarbazine—brain cancer	0.00249	0.00258	CcSEcCtD
Pamidronate—Erythema—Hydroxyurea—brain cancer	0.00247	0.00256	CcSEcCtD
Pamidronate—Infestation—Temozolomide—brain cancer	0.00247	0.00256	CcSEcCtD
Pamidronate—Infestation NOS—Temozolomide—brain cancer	0.00247	0.00256	CcSEcCtD
Pamidronate—Nausea—Lomustine—brain cancer	0.00244	0.00253	CcSEcCtD
Pamidronate—Hypotension—Procarbazine—brain cancer	0.00244	0.00253	CcSEcCtD
Pamidronate—Stomatitis—Temozolomide—brain cancer	0.00241	0.0025	CcSEcCtD
Pamidronate—Urinary tract infection—Temozolomide—brain cancer	0.0024	0.00249	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Procarbazine—brain cancer	0.00238	0.00246	CcSEcCtD
Pamidronate—Insomnia—Procarbazine—brain cancer	0.00236	0.00244	CcSEcCtD
Pamidronate—FDPS—midbrain—brain cancer	0.00236	0.0935	CbGeAlD
Pamidronate—Paraesthesia—Procarbazine—brain cancer	0.00234	0.00243	CcSEcCtD
Pamidronate—Sinusitis—Temozolomide—brain cancer	0.00232	0.0024	CcSEcCtD
Pamidronate—Somnolence—Procarbazine—brain cancer	0.00232	0.0024	CcSEcCtD
Pamidronate—Cramp muscle—Etoposide—brain cancer	0.00231	0.0024	CcSEcCtD
Pamidronate—Haemoglobin—Carmustine—brain cancer	0.00231	0.00239	CcSEcCtD
Pamidronate—FDPS—spinal cord—brain cancer	0.0023	0.0912	CbGeAlD
Pamidronate—Haemorrhage—Carmustine—brain cancer	0.0023	0.00238	CcSEcCtD
Pamidronate—Ill-defined disorder—Hydroxyurea—brain cancer	0.0023	0.00238	CcSEcCtD
Pamidronate—Anaemia—Hydroxyurea—brain cancer	0.00229	0.00237	CcSEcCtD
Pamidronate—Decreased appetite—Procarbazine—brain cancer	0.00227	0.00235	CcSEcCtD
Pamidronate—Connective tissue disorder—Carmustine—brain cancer	0.00226	0.00234	CcSEcCtD
Pamidronate—Fatigue—Procarbazine—brain cancer	0.00225	0.00233	CcSEcCtD
Pamidronate—Haemoglobin—Temozolomide—brain cancer	0.00223	0.00231	CcSEcCtD
Pamidronate—Malaise—Hydroxyurea—brain cancer	0.00223	0.00231	CcSEcCtD
Pamidronate—Pain—Procarbazine—brain cancer	0.00223	0.00231	CcSEcCtD
Pamidronate—Constipation—Procarbazine—brain cancer	0.00223	0.00231	CcSEcCtD
Pamidronate—Haemorrhage—Temozolomide—brain cancer	0.00222	0.0023	CcSEcCtD
Pamidronate—Leukopenia—Hydroxyurea—brain cancer	0.00221	0.00229	CcSEcCtD
Pamidronate—Urinary tract disorder—Temozolomide—brain cancer	0.00219	0.00227	CcSEcCtD
Pamidronate—Bronchospasm—Etoposide—brain cancer	0.00218	0.00226	CcSEcCtD
Pamidronate—Connective tissue disorder—Temozolomide—brain cancer	0.00218	0.00226	CcSEcCtD
Pamidronate—Urethral disorder—Temozolomide—brain cancer	0.00218	0.00225	CcSEcCtD
Pamidronate—Sweating increased—Etoposide—brain cancer	0.00216	0.00224	CcSEcCtD
Pamidronate—Feeling abnormal—Procarbazine—brain cancer	0.00215	0.00223	CcSEcCtD
Pamidronate—Eye disorder—Carmustine—brain cancer	0.00215	0.00222	CcSEcCtD
Pamidronate—Convulsion—Hydroxyurea—brain cancer	0.00214	0.00222	CcSEcCtD
Pamidronate—Gastrointestinal pain—Procarbazine—brain cancer	0.00213	0.00221	CcSEcCtD
Pamidronate—Flushing—Carmustine—brain cancer	0.00213	0.00221	CcSEcCtD
Pamidronate—Discomfort—Hydroxyurea—brain cancer	0.00208	0.00216	CcSEcCtD
Pamidronate—Neutropenia—Etoposide—brain cancer	0.00208	0.00215	CcSEcCtD
Pamidronate—Eye disorder—Temozolomide—brain cancer	0.00208	0.00215	CcSEcCtD
Pamidronate—FDPS—endocrine gland—brain cancer	0.00207	0.0821	CbGeAlD
Pamidronate—Abdominal pain—Procarbazine—brain cancer	0.00206	0.00214	CcSEcCtD
Pamidronate—Body temperature increased—Procarbazine—brain cancer	0.00206	0.00214	CcSEcCtD
Pamidronate—Cardiac disorder—Temozolomide—brain cancer	0.00206	0.00213	CcSEcCtD
Pamidronate—Flushing—Temozolomide—brain cancer	0.00206	0.00213	CcSEcCtD
Pamidronate—FDPS—head—brain cancer	0.00204	0.081	CbGeAlD
Pamidronate—Alopecia—Carmustine—brain cancer	0.00203	0.0021	CcSEcCtD
Pamidronate—Oedema—Hydroxyurea—brain cancer	0.00202	0.00209	CcSEcCtD
Pamidronate—Angiopathy—Temozolomide—brain cancer	0.00201	0.00209	CcSEcCtD
Pamidronate—Infection—Hydroxyurea—brain cancer	0.00201	0.00208	CcSEcCtD
Pamidronate—Immune system disorder—Temozolomide—brain cancer	0.00201	0.00208	CcSEcCtD
Pamidronate—Mediastinal disorder—Temozolomide—brain cancer	0.002	0.00207	CcSEcCtD
Pamidronate—Malnutrition—Carmustine—brain cancer	0.002	0.00207	CcSEcCtD
Pamidronate—Erythema—Carmustine—brain cancer	0.002	0.00207	CcSEcCtD
Pamidronate—Chills—Temozolomide—brain cancer	0.00199	0.00206	CcSEcCtD
Pamidronate—Pneumonia—Etoposide—brain cancer	0.00199	0.00206	CcSEcCtD
Pamidronate—Nervous system disorder—Hydroxyurea—brain cancer	0.00198	0.00205	CcSEcCtD
Pamidronate—Infestation—Etoposide—brain cancer	0.00198	0.00205	CcSEcCtD
Pamidronate—Infestation NOS—Etoposide—brain cancer	0.00198	0.00205	CcSEcCtD
Pamidronate—Thrombocytopenia—Hydroxyurea—brain cancer	0.00198	0.00205	CcSEcCtD
Pamidronate—Alopecia—Temozolomide—brain cancer	0.00196	0.00203	CcSEcCtD
Pamidronate—Renal failure—Etoposide—brain cancer	0.00195	0.00202	CcSEcCtD
Pamidronate—Back pain—Carmustine—brain cancer	0.00193	0.002	CcSEcCtD
Pamidronate—Erythema—Temozolomide—brain cancer	0.00193	0.002	CcSEcCtD
Pamidronate—Malnutrition—Temozolomide—brain cancer	0.00193	0.002	CcSEcCtD
Pamidronate—Stomatitis—Etoposide—brain cancer	0.00193	0.002	CcSEcCtD
Pamidronate—Anorexia—Hydroxyurea—brain cancer	0.00192	0.00199	CcSEcCtD
Pamidronate—Hypersensitivity—Procarbazine—brain cancer	0.00192	0.00199	CcSEcCtD
Pamidronate—Dysgeusia—Temozolomide—brain cancer	0.00189	0.00196	CcSEcCtD
Pamidronate—Asthenia—Procarbazine—brain cancer	0.00187	0.00194	CcSEcCtD
Pamidronate—Back pain—Temozolomide—brain cancer	0.00187	0.00194	CcSEcCtD
Pamidronate—FDPS—central nervous system—brain cancer	0.00186	0.074	CbGeAlD
Pamidronate—Anaemia—Carmustine—brain cancer	0.00185	0.00191	CcSEcCtD
Pamidronate—Agranulocytosis—Etoposide—brain cancer	0.00185	0.00191	CcSEcCtD
Pamidronate—Pruritus—Procarbazine—brain cancer	0.00185	0.00191	CcSEcCtD
Pamidronate—Agitation—Carmustine—brain cancer	0.00184	0.0019	CcSEcCtD
Pamidronate—FDPS—cerebellum—brain cancer	0.00182	0.0723	CbGeAlD
Pamidronate—Dyspnoea—Hydroxyurea—brain cancer	0.0018	0.00186	CcSEcCtD
Pamidronate—Somnolence—Hydroxyurea—brain cancer	0.0018	0.00186	CcSEcCtD
Pamidronate—Ill-defined disorder—Temozolomide—brain cancer	0.00179	0.00186	CcSEcCtD
Pamidronate—Leukopenia—Carmustine—brain cancer	0.00179	0.00185	CcSEcCtD
Pamidronate—Anaemia—Temozolomide—brain cancer	0.00179	0.00185	CcSEcCtD
Pamidronate—Diarrhoea—Procarbazine—brain cancer	0.00179	0.00185	CcSEcCtD
Pamidronate—Dyspepsia—Hydroxyurea—brain cancer	0.00178	0.00184	CcSEcCtD
Pamidronate—Agitation—Temozolomide—brain cancer	0.00178	0.00184	CcSEcCtD
Pamidronate—Angioedema—Temozolomide—brain cancer	0.00177	0.00183	CcSEcCtD
Pamidronate—Decreased appetite—Hydroxyurea—brain cancer	0.00176	0.00182	CcSEcCtD
Pamidronate—Urinary tract disorder—Etoposide—brain cancer	0.00175	0.00182	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.00174	0.00181	CcSEcCtD
Pamidronate—Malaise—Temozolomide—brain cancer	0.00174	0.00181	CcSEcCtD
Pamidronate—Urethral disorder—Etoposide—brain cancer	0.00174	0.0018	CcSEcCtD
Pamidronate—Fatigue—Hydroxyurea—brain cancer	0.00174	0.0018	CcSEcCtD
Pamidronate—Convulsion—Carmustine—brain cancer	0.00173	0.00179	CcSEcCtD
Pamidronate—Leukopenia—Temozolomide—brain cancer	0.00173	0.00179	CcSEcCtD
Pamidronate—Hypertension—Carmustine—brain cancer	0.00173	0.00179	CcSEcCtD
Pamidronate—Constipation—Hydroxyurea—brain cancer	0.00173	0.00179	CcSEcCtD
Pamidronate—Pain—Hydroxyurea—brain cancer	0.00173	0.00179	CcSEcCtD
Pamidronate—Dizziness—Procarbazine—brain cancer	0.00173	0.00179	CcSEcCtD
Pamidronate—Myalgia—Carmustine—brain cancer	0.0017	0.00176	CcSEcCtD
Pamidronate—Anxiety—Carmustine—brain cancer	0.0017	0.00176	CcSEcCtD
Pamidronate—Cough—Temozolomide—brain cancer	0.00169	0.00175	CcSEcCtD
Pamidronate—Convulsion—Temozolomide—brain cancer	0.00167	0.00173	CcSEcCtD
Pamidronate—Hypertension—Temozolomide—brain cancer	0.00167	0.00173	CcSEcCtD
Pamidronate—Feeling abnormal—Hydroxyurea—brain cancer	0.00166	0.00172	CcSEcCtD
Pamidronate—Eye disorder—Etoposide—brain cancer	0.00166	0.00172	CcSEcCtD
Pamidronate—Vomiting—Procarbazine—brain cancer	0.00166	0.00172	CcSEcCtD
Pamidronate—Flushing—Etoposide—brain cancer	0.00165	0.00171	CcSEcCtD
Pamidronate—Cardiac disorder—Etoposide—brain cancer	0.00165	0.00171	CcSEcCtD
Pamidronate—Confusional state—Carmustine—brain cancer	0.00165	0.0017	CcSEcCtD
Pamidronate—Arthralgia—Temozolomide—brain cancer	0.00165	0.0017	CcSEcCtD
Pamidronate—Myalgia—Temozolomide—brain cancer	0.00165	0.0017	CcSEcCtD
Pamidronate—Rash—Procarbazine—brain cancer	0.00165	0.0017	CcSEcCtD
Pamidronate—Dermatitis—Procarbazine—brain cancer	0.00164	0.0017	CcSEcCtD
Pamidronate—Anxiety—Temozolomide—brain cancer	0.00164	0.0017	CcSEcCtD
Pamidronate—Headache—Procarbazine—brain cancer	0.00163	0.00169	CcSEcCtD
Pamidronate—Oedema—Carmustine—brain cancer	0.00163	0.00169	CcSEcCtD
Pamidronate—Discomfort—Temozolomide—brain cancer	0.00163	0.00168	CcSEcCtD
Pamidronate—Infection—Carmustine—brain cancer	0.00162	0.00168	CcSEcCtD
Pamidronate—Angiopathy—Etoposide—brain cancer	0.00161	0.00167	CcSEcCtD
Pamidronate—Immune system disorder—Etoposide—brain cancer	0.0016	0.00166	CcSEcCtD
Pamidronate—Mediastinal disorder—Etoposide—brain cancer	0.0016	0.00166	CcSEcCtD
Pamidronate—Thrombocytopenia—Carmustine—brain cancer	0.0016	0.00166	CcSEcCtD
Pamidronate—Body temperature increased—Hydroxyurea—brain cancer	0.0016	0.00165	CcSEcCtD
Pamidronate—Chills—Etoposide—brain cancer	0.00159	0.00165	CcSEcCtD
Pamidronate—Tachycardia—Carmustine—brain cancer	0.00159	0.00165	CcSEcCtD
Pamidronate—Confusional state—Temozolomide—brain cancer	0.00159	0.00165	CcSEcCtD
Pamidronate—Oedema—Temozolomide—brain cancer	0.00158	0.00163	CcSEcCtD
Pamidronate—Anaphylactic shock—Temozolomide—brain cancer	0.00158	0.00163	CcSEcCtD
Pamidronate—Alopecia—Etoposide—brain cancer	0.00157	0.00163	CcSEcCtD
Pamidronate—Infection—Temozolomide—brain cancer	0.00157	0.00162	CcSEcCtD
Pamidronate—Anorexia—Carmustine—brain cancer	0.00156	0.00161	CcSEcCtD
Pamidronate—Nausea—Procarbazine—brain cancer	0.00155	0.00161	CcSEcCtD
Pamidronate—Nervous system disorder—Temozolomide—brain cancer	0.00155	0.0016	CcSEcCtD
Pamidronate—Thrombocytopenia—Temozolomide—brain cancer	0.00154	0.0016	CcSEcCtD
Pamidronate—Hypotension—Carmustine—brain cancer	0.00153	0.00158	CcSEcCtD
Pamidronate—Hyperhidrosis—Temozolomide—brain cancer	0.00153	0.00158	CcSEcCtD
Pamidronate—Dysgeusia—Etoposide—brain cancer	0.00151	0.00157	CcSEcCtD
Pamidronate—Anorexia—Temozolomide—brain cancer	0.0015	0.00156	CcSEcCtD
Pamidronate—Back pain—Etoposide—brain cancer	0.0015	0.00155	CcSEcCtD
Pamidronate—Hypersensitivity—Hydroxyurea—brain cancer	0.00149	0.00154	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Carmustine—brain cancer	0.00149	0.00154	CcSEcCtD
Pamidronate—Muscle spasms—Etoposide—brain cancer	0.00149	0.00154	CcSEcCtD
Pamidronate—FDPS—brain—brain cancer	0.00148	0.0587	CbGeAlD
Pamidronate—Insomnia—Carmustine—brain cancer	0.00148	0.00153	CcSEcCtD
Pamidronate—Paraesthesia—Carmustine—brain cancer	0.00147	0.00152	CcSEcCtD
Pamidronate—Dyspnoea—Carmustine—brain cancer	0.00146	0.00151	CcSEcCtD
Pamidronate—Somnolence—Carmustine—brain cancer	0.00145	0.0015	CcSEcCtD
Pamidronate—Asthenia—Hydroxyurea—brain cancer	0.00145	0.0015	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Temozolomide—brain cancer	0.00144	0.00149	CcSEcCtD
Pamidronate—Ill-defined disorder—Etoposide—brain cancer	0.00144	0.00149	CcSEcCtD
Pamidronate—Anaemia—Etoposide—brain cancer	0.00143	0.00148	CcSEcCtD
Pamidronate—Insomnia—Temozolomide—brain cancer	0.00143	0.00148	CcSEcCtD
Pamidronate—Decreased appetite—Carmustine—brain cancer	0.00142	0.00147	CcSEcCtD
Pamidronate—Paraesthesia—Temozolomide—brain cancer	0.00142	0.00147	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Carmustine—brain cancer	0.00141	0.00146	CcSEcCtD
Pamidronate—Dyspnoea—Temozolomide—brain cancer	0.00141	0.00146	CcSEcCtD
Pamidronate—Somnolence—Temozolomide—brain cancer	0.0014	0.00145	CcSEcCtD
Pamidronate—Pain—Carmustine—brain cancer	0.0014	0.00145	CcSEcCtD
Pamidronate—Constipation—Carmustine—brain cancer	0.0014	0.00145	CcSEcCtD
Pamidronate—Malaise—Etoposide—brain cancer	0.00139	0.00144	CcSEcCtD
Pamidronate—Dyspepsia—Temozolomide—brain cancer	0.00139	0.00144	CcSEcCtD
Pamidronate—Leukopenia—Etoposide—brain cancer	0.00138	0.00143	CcSEcCtD
Pamidronate—Diarrhoea—Hydroxyurea—brain cancer	0.00138	0.00143	CcSEcCtD
Pamidronate—Decreased appetite—Temozolomide—brain cancer	0.00137	0.00142	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Temozolomide—brain cancer	0.00136	0.00141	CcSEcCtD
Pamidronate—Fatigue—Temozolomide—brain cancer	0.00136	0.00141	CcSEcCtD
Pamidronate—Loss of consciousness—Etoposide—brain cancer	0.00136	0.00141	CcSEcCtD
Pamidronate—Cough—Etoposide—brain cancer	0.00135	0.0014	CcSEcCtD
Pamidronate—Constipation—Temozolomide—brain cancer	0.00135	0.0014	CcSEcCtD
Pamidronate—Pain—Temozolomide—brain cancer	0.00135	0.0014	CcSEcCtD
Pamidronate—Feeling abnormal—Carmustine—brain cancer	0.00135	0.00139	CcSEcCtD
Pamidronate—Convulsion—Etoposide—brain cancer	0.00134	0.00139	CcSEcCtD
Pamidronate—Hypertension—Etoposide—brain cancer	0.00134	0.00138	CcSEcCtD
Pamidronate—Dizziness—Hydroxyurea—brain cancer	0.00134	0.00138	CcSEcCtD
Pamidronate—Gastrointestinal pain—Carmustine—brain cancer	0.00133	0.00138	CcSEcCtD
Pamidronate—Discomfort—Etoposide—brain cancer	0.0013	0.00135	CcSEcCtD
Pamidronate—Feeling abnormal—Temozolomide—brain cancer	0.0013	0.00135	CcSEcCtD
Pamidronate—Abdominal pain—Carmustine—brain cancer	0.00129	0.00134	CcSEcCtD
Pamidronate—Body temperature increased—Carmustine—brain cancer	0.00129	0.00134	CcSEcCtD
Pamidronate—Gastrointestinal pain—Temozolomide—brain cancer	0.00129	0.00134	CcSEcCtD
Pamidronate—Vomiting—Hydroxyurea—brain cancer	0.00128	0.00133	CcSEcCtD
Pamidronate—Rash—Hydroxyurea—brain cancer	0.00127	0.00132	CcSEcCtD
Pamidronate—Confusional state—Etoposide—brain cancer	0.00127	0.00132	CcSEcCtD
Pamidronate—Dermatitis—Hydroxyurea—brain cancer	0.00127	0.00132	CcSEcCtD
Pamidronate—Headache—Hydroxyurea—brain cancer	0.00127	0.00131	CcSEcCtD
Pamidronate—Anaphylactic shock—Etoposide—brain cancer	0.00126	0.00131	CcSEcCtD
Pamidronate—Infection—Etoposide—brain cancer	0.00125	0.0013	CcSEcCtD
Pamidronate—Abdominal pain—Temozolomide—brain cancer	0.00125	0.00129	CcSEcCtD
Pamidronate—Body temperature increased—Temozolomide—brain cancer	0.00125	0.00129	CcSEcCtD
Pamidronate—Thrombocytopenia—Etoposide—brain cancer	0.00124	0.00128	CcSEcCtD
Pamidronate—Tachycardia—Etoposide—brain cancer	0.00123	0.00128	CcSEcCtD
Pamidronate—Hyperhidrosis—Etoposide—brain cancer	0.00122	0.00126	CcSEcCtD
Pamidronate—Anorexia—Etoposide—brain cancer	0.0012	0.00125	CcSEcCtD
Pamidronate—Hypersensitivity—Carmustine—brain cancer	0.0012	0.00125	CcSEcCtD
Pamidronate—Nausea—Hydroxyurea—brain cancer	0.0012	0.00124	CcSEcCtD
Pamidronate—Hypotension—Etoposide—brain cancer	0.00118	0.00122	CcSEcCtD
Pamidronate—Asthenia—Carmustine—brain cancer	0.00117	0.00121	CcSEcCtD
Pamidronate—Hypersensitivity—Temozolomide—brain cancer	0.00116	0.0012	CcSEcCtD
Pamidronate—Paraesthesia—Etoposide—brain cancer	0.00113	0.00117	CcSEcCtD
Pamidronate—Asthenia—Temozolomide—brain cancer	0.00113	0.00117	CcSEcCtD
Pamidronate—Dyspnoea—Etoposide—brain cancer	0.00113	0.00117	CcSEcCtD
Pamidronate—Somnolence—Etoposide—brain cancer	0.00112	0.00116	CcSEcCtD
Pamidronate—Diarrhoea—Carmustine—brain cancer	0.00112	0.00116	CcSEcCtD
Pamidronate—Pruritus—Temozolomide—brain cancer	0.00112	0.00116	CcSEcCtD
Pamidronate—Decreased appetite—Etoposide—brain cancer	0.0011	0.00114	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Etoposide—brain cancer	0.00109	0.00113	CcSEcCtD
Pamidronate—Fatigue—Etoposide—brain cancer	0.00109	0.00113	CcSEcCtD
Pamidronate—Dizziness—Carmustine—brain cancer	0.00108	0.00112	CcSEcCtD
Pamidronate—Constipation—Etoposide—brain cancer	0.00108	0.00112	CcSEcCtD
Pamidronate—Pain—Etoposide—brain cancer	0.00108	0.00112	CcSEcCtD
Pamidronate—Diarrhoea—Temozolomide—brain cancer	0.00108	0.00112	CcSEcCtD
Pamidronate—Dizziness—Temozolomide—brain cancer	0.00104	0.00108	CcSEcCtD
Pamidronate—Feeling abnormal—Etoposide—brain cancer	0.00104	0.00108	CcSEcCtD
Pamidronate—Vomiting—Carmustine—brain cancer	0.00104	0.00107	CcSEcCtD
Pamidronate—Gastrointestinal pain—Etoposide—brain cancer	0.00103	0.00107	CcSEcCtD
Pamidronate—Rash—Carmustine—brain cancer	0.00103	0.00107	CcSEcCtD
Pamidronate—Dermatitis—Carmustine—brain cancer	0.00103	0.00107	CcSEcCtD
Pamidronate—Headache—Carmustine—brain cancer	0.00102	0.00106	CcSEcCtD
Pamidronate—Vomiting—Temozolomide—brain cancer	0.001	0.00104	CcSEcCtD
Pamidronate—Abdominal pain—Etoposide—brain cancer	0.000998	0.00103	CcSEcCtD
Pamidronate—Body temperature increased—Etoposide—brain cancer	0.000998	0.00103	CcSEcCtD
Pamidronate—Rash—Temozolomide—brain cancer	0.000995	0.00103	CcSEcCtD
Pamidronate—Dermatitis—Temozolomide—brain cancer	0.000994	0.00103	CcSEcCtD
Pamidronate—Headache—Temozolomide—brain cancer	0.000988	0.00102	CcSEcCtD
Pamidronate—Nausea—Carmustine—brain cancer	0.00097	0.001	CcSEcCtD
Pamidronate—Nausea—Temozolomide—brain cancer	0.000937	0.000971	CcSEcCtD
Pamidronate—Hypersensitivity—Etoposide—brain cancer	0.00093	0.000963	CcSEcCtD
Pamidronate—Asthenia—Etoposide—brain cancer	0.000906	0.000938	CcSEcCtD
Pamidronate—Pruritus—Etoposide—brain cancer	0.000893	0.000925	CcSEcCtD
Pamidronate—Diarrhoea—Etoposide—brain cancer	0.000864	0.000895	CcSEcCtD
Pamidronate—Dizziness—Etoposide—brain cancer	0.000835	0.000865	CcSEcCtD
Pamidronate—Vomiting—Etoposide—brain cancer	0.000803	0.000831	CcSEcCtD
Pamidronate—Rash—Etoposide—brain cancer	0.000796	0.000824	CcSEcCtD
Pamidronate—Dermatitis—Etoposide—brain cancer	0.000795	0.000824	CcSEcCtD
Pamidronate—Headache—Etoposide—brain cancer	0.000791	0.000819	CcSEcCtD
Pamidronate—Nausea—Etoposide—brain cancer	0.00075	0.000777	CcSEcCtD
